This topic contains a solution. Click here to go to the answer

Author Question: Amylopectin sub-units are linked together by (1) 1,4-a-glucosidic linkages, (2) 1,6-a-glucosidic ... (Read 41 times)

humphriesbr@me.com

  • Hero Member
  • *****
  • Posts: 550
Amylopectin sub-units are linked together by
 
  (1) 1,4-a-glucosidic linkages, (2) 1,6-a-glucosidic linkages, (3) salt bridges, (4) 1,4- and 1,6-a-glucosidic linkages, (5) van der Waals forces.

Question 2

Discuss the burden of proof provision of the Food Additives Amendment of 1958.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

BAOCHAU2803

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

4

Answer to Question 2

The Food and Drug Administration transferred the burden of proof from the government to industry. Industry now has to prove to the government that a food additive has been tested for safety, before the additive can be approved.




humphriesbr@me.com

  • Member
  • Posts: 550
Reply 2 on: Aug 2, 2018
Thanks for the timely response, appreciate it


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library